Naoki Kishimoto

3.9k total citations
68 papers, 2.1k citations indexed

About

Naoki Kishimoto is a scholar working on Plant Science, Molecular Biology and Virology. According to data from OpenAlex, Naoki Kishimoto has authored 68 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Plant Science, 29 papers in Molecular Biology and 11 papers in Virology. Recurrent topics in Naoki Kishimoto's work include HIV Research and Treatment (11 papers), Plant Molecular Biology Research (10 papers) and HIV/AIDS drug development and treatment (9 papers). Naoki Kishimoto is often cited by papers focused on HIV Research and Treatment (11 papers), Plant Molecular Biology Research (10 papers) and HIV/AIDS drug development and treatment (9 papers). Naoki Kishimoto collaborates with scholars based in Japan, United States and Egypt. Naoki Kishimoto's co-authors include Shoshi Kikuchi, Junshi Yazaki, Akira Saito, Shogo Misumi, Katsumi Sakata, Kanako Shimbo, Kimiko Yamamoto, Fumiko Fujii, Nobutoki Takamune and Hiromi Nakanishi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Naoki Kishimoto

65 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Kishimoto Japan 23 1.5k 879 226 116 81 68 2.1k
Shu Wei China 28 667 0.4× 1.1k 1.3× 112 0.5× 151 1.3× 209 2.6× 88 2.3k
Yue Zhao China 26 1.2k 0.8× 866 1.0× 284 1.3× 100 0.9× 14 0.2× 81 2.1k
W. Mark Toone United Kingdom 18 551 0.4× 2.4k 2.7× 197 0.9× 147 1.3× 62 0.8× 21 2.8k
Pradhyumna Kumar Singh India 25 932 0.6× 1.4k 1.6× 120 0.5× 95 0.8× 30 0.4× 65 2.1k
Mary B. Slabaugh United States 28 1.3k 0.8× 986 1.1× 579 2.6× 58 0.5× 193 2.4× 54 2.2k
Xue Yang China 21 1.3k 0.8× 883 1.0× 300 1.3× 18 0.2× 22 0.3× 91 1.8k
John D. Williamson United States 26 1.6k 1.0× 1.2k 1.4× 86 0.4× 32 0.3× 16 0.2× 57 2.4k
Mariolina Gullì Italy 22 1.1k 0.7× 786 0.9× 212 0.9× 15 0.1× 52 0.6× 52 1.7k
K. Ehrlich United States 22 1.5k 1.0× 775 0.9× 57 0.3× 54 0.5× 18 0.2× 56 2.1k
Subhra Chakraborty India 30 2.1k 1.4× 1.3k 1.5× 155 0.7× 26 0.2× 11 0.1× 106 2.8k

Countries citing papers authored by Naoki Kishimoto

Since Specialization
Citations

This map shows the geographic impact of Naoki Kishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Kishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Kishimoto more than expected).

Fields of papers citing papers by Naoki Kishimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Kishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Kishimoto. The network helps show where Naoki Kishimoto may publish in the future.

Co-authorship network of co-authors of Naoki Kishimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Kishimoto. A scholar is included among the top collaborators of Naoki Kishimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Kishimoto. Naoki Kishimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tanaka, Hiroki, Shunsuke Kita, Hiroyuki Takeda, et al.. (2025). Structural basis of the hepatitis B virus X protein in complex with DDB1. Proceedings of the National Academy of Sciences. 122(24). e2421325122–e2421325122.
3.
Elamin, Khaled M., Naoki Kishimoto, Teppei Kawahara, et al.. (2025). Ethnopharmacological exploration and isolation of HIV-1 latency-reversing agents from Sudanese medicinal plants. Frontiers in Pharmacology. 16. 1587128–1587128.
4.
Nagatomo, Masanori, Akira Hirose, Naoki Kishimoto, et al.. (2024). Total Syntheses of Phorbol and 11 Tigliane Diterpenoids and Their Evaluation as HIV Latency-Reversing Agents. Journal of the American Chemical Society. 146(12). 8746–8756. 12 indexed citations
5.
Kishimoto, Naoki, Satoshi Miura, Jun‐ichi Haruta, et al.. (2023). Synthesis and Biological Evaluation of Simplified Ansellone Analogues with Lipophilic Side Chains as HIV Latency‐Reversing Agents. Chemistry - A European Journal. 29(44). e202300677–e202300677. 1 indexed citations
6.
Kishimoto, Naoki, Satoshi Miura, Shogo Misumi, et al.. (2022). Total Synthesis of Ansellone G and Phorbadione. The Journal of Organic Chemistry. 87(24). 16913–16917. 4 indexed citations
7.
El‐Desoky, Ahmed H., Keisuke Eguchi, Naoki Kishimoto, et al.. (2022). Isolation, Synthesis, and Structure–Activity Relationship Study on Daphnane and Tigliane Diterpenes as HIV Latency-Reversing Agents. Journal of Medicinal Chemistry. 65(4). 3460–3472. 19 indexed citations
8.
Murai, Kenichi, et al.. (2021). Total Synthesis and Biological Evaluation of the Potent HIV Latency-Reversing Agent Ansellone A and its Analogues. Organic Letters. 23(5). 1720–1725. 12 indexed citations
9.
Higashi‐Kuwata, Nobuyo, Sanae Hayashi, Hiroki Kumamoto, et al.. (2020). Identification of a novel long-acting 4’-modified nucleoside reverse transcriptase inhibitor against HBV. Journal of Hepatology. 74(5). 1075–1086. 21 indexed citations
10.
Devkota, Hari Prasad, Mikiyo Wada, Naoki Kishimoto, et al.. (2018). Free radical scavenging, α-glucosidase inhibitory and lipase inhibitory activities of eighteen Sudanese medicinal plants. BMC Complementary and Alternative Medicine. 18(1). 282–282. 34 indexed citations
11.
Kishimoto, Naoki, et al.. (2017). Virion-incorporated alpha-enolase suppresses the early stage of HIV-1 reverse transcription. Biochemical and Biophysical Research Communications. 484(2). 278–284. 14 indexed citations
12.
13.
Ogawa‐Tominaga, Minako, Yuki Takemoto, Daisuke Inoue, et al.. (2015). ATP generation in a host cell in early-phase infection is increased by upregulation of cytochrome c oxidase activity via the p2 peptide from human immunodeficiency virus type 1 Gag. Retrovirology. 12(1). 97–97. 16 indexed citations
14.
Takamune, Nobutoki, et al.. (2015). N -myristoyltransferase 1 enhances human immunodeficiency virus replication through regulation of viral RNA expression level. Biochemical and Biophysical Research Communications. 463(4). 988–993. 5 indexed citations
15.
Kishimoto, Naoki, et al.. (2013). DNA Elements Reducing Transcriptional Gene Silencing Revealed by a Novel Screening Strategy. PLoS ONE. 8(1). e54670–e54670. 4 indexed citations
16.
Misumi, Shogo, M. Inoue, Naoki Kishimoto, et al.. (2010). Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1. Journal of Biological Chemistry. 285(33). 25185–25195. 53 indexed citations
17.
Suzuki, Motofumi, Michiko Takahashi, Takashi Tsukamoto, et al.. (2006). Biosynthesis and secretion of mugineic acid family phytosiderophores in zinc‐deficient barley. The Plant Journal. 48(1). 85–97. 180 indexed citations
18.
Kawasaki, Tsutomu, et al.. (1999). RNA maturation of the rice SPK gene may involve trans‐splicing. The Plant Journal. 18(6). 625–632. 21 indexed citations
19.
Kishimoto, Naoki, Kenichi Higo, Hiromi Higo, & Akira Saito. (1994). The coding sequence for rice seed catalase detects a locus different from that determined by isozyme analysis. Theoretical and Applied Genetics. 87(6). 625–626. 5 indexed citations
20.
Kishimoto, Naoki, et al.. (1994). Identification of the duplicated segments in rice chromosomes 1 and 5 by linkage analysis of cDNA markers of known functions. Theoretical and Applied Genetics. 88(6-7). 722–726. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shu Wei Breakdown of academic impact, for papers by Yue Zhao Breakdown of academic impact, for papers by W. Mark Toone Breakdown of academic impact, for papers by Pradhyumna Kumar Singh Breakdown of academic impact, for papers by Mary B. Slabaugh Breakdown of academic impact, for papers by Xue Yang Breakdown of academic impact, for papers by John D. Williamson Breakdown of academic impact, for papers by Mariolina Gullì Breakdown of academic impact, for papers by K. Ehrlich Breakdown of academic impact, for papers by Subhra Chakraborty
Rankless by CCL
2026